A Novel, Heterozygous, de novo Splicing Variant Affecting the Intracellular Domain of the Growth Hormone Receptor, and Causing a Mild Short Stature
Hormone Research in Paediatrics · 2024
DOI: 10.1159/000534183 ↗Kurz gefasst
Fallbericht in der Zeitschrift Hormone Research in Paediatrics, 2024. Verfasst von Aristeidis Giannakopoulos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Pediatrics, Medical School, University of Patras, Patras, Greece. Hauptthemen laut MEDLINE: Receptors, Somatotropin.
Abstract (Originalsprache)
Introduction
Although the majority of growth hormone insensitivity syndrome (GHIS) cases are classical, the spectrum of clinical phenotypes has expanded to include “atypical” GHIS subjects with milder phenotypes due to very rare heterozygous growth hormone receptor (GHR) mutations with dominant negative effects. Case Presentation: A 13-year-old pubertal boy presented with short stature (−1.7 SDS) and delayed bone age (11.5 years). His serum IGF-1 was low (16 ng/mL; reference range: 179–540). IGFBP-3 (1.3 mg/L; 3.1–9.5) and ALS (565 mU/mL; 1,500–3,500) were also low. GH stimulation test was normal, and GHBP was markedly elevated (6,300 pmol/L; 240–3,000). Additionally, the boy had insulin resistance and liver steatosis. His final height reached −1.8 SDS, which was 3.0 SDS below his mid-parental height. GHR gene from genomic DNA and established primary fibroblast culture was analyzed and a synonymous heterozygous GHR: c.945G>A variant, in the last nucleotide of exon 9 (encoding intracellular domain of GHR) was identified. In vitro analysis of the GHR cDNA demonstrated a splicing defect, leading to the heterozygous excision of exon 9. The final predicted product was a truncated GHR protein which explained the elevated GHBP levels.
Conclusion
We describe the first synonymous heterozygous GHR splicing variant in the exon 9-encoding part of the intracellular domain of GHR identified in a patient with mild short stature, thus supporting the continuum of genotype-phenotype of GHIS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Department of Pediatrics, Medical School, University of Patras, Patras, Greece.
- Department of Biology Medical School, University of Patras, Patras, Greece.
- Division of Endocrinology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, Ohio, USA.
Zitieren
APA
Giannakopoulos, A., Papanastasiou, A. D., Zarkadis, I. K., Andrew, S. F., Rosenfeld, R. G., Efthymiadou, A., Chrysis, D., & Hwa, V. (2024). A Novel, Heterozygous, de novo Splicing Variant Affecting the Intracellular Domain of the Growth Hormone Receptor, and Causing a Mild Short Stature. Hormone Research in Paediatrics. https://doi.org/10.1159/000534183
Vancouver
Giannakopoulos A, Papanastasiou AD, Zarkadis IK, Andrew SF, Rosenfeld RG, Efthymiadou A, et al. A Novel, Heterozygous, de novo Splicing Variant Affecting the Intracellular Domain of the Growth Hormone Receptor, and Causing a Mild Short Stature. Hormone Research in Paediatrics. 2024. doi:10.1159/000534183
BibTeX
@article{Giannakopoulos2024,
author = {Giannakopoulos, Aristeidis and Papanastasiou, Anastasios D and Zarkadis, Ioannis K and Andrew, Shayne F and Rosenfeld, Ron G and Efthymiadou, Alexandra and Chrysis, Dionisios and Hwa, Vivian},
title = {A Novel, Heterozygous, de novo Splicing Variant Affecting the Intracellular Domain of the Growth Hormone Receptor, and Causing a Mild Short Stature},
journal = {Hormone Research in Paediatrics},
year = {2024},
doi = {10.1159/000534183}
}
EUVIMED